Clinical Trials Directory

Trials / Completed

CompletedNCT00197353

Study of Different Concentrations of Epidural Bupivacaine for the Effects on Vasodilatation and Sensory Block

Sympathectomy-Mediated Vasodilatation and Differential Sensory Block After Epidural Bupivacaine: a Randomized Concentration Ranging Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
60 (planned)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare human subjects receiving epidural bupivacaine local anesthetic at different doses and concentrations and to assess the effect on vasodilatation (sympathectomy), sensory and motor block. The hypothesis is that the drug concentration is more important than drug dose in the determination of the extent and intensity of differential sympathetic, sensory and motor block following epidural local anesthetic.

Detailed description

There is controversy regarding the factors that determine the extent and intensity of epidural drug action. Most studies have focused on the inter-related triad of dose, concentration and volume. We compare three groups: group A: 10ml of 0.5% bupivacaine; group B: 10ml of 0.25% bupivacaine and group C: 40ml of 0.0625% bupivacaine. When comparing these groups, groups A \& B have the same volume of epidural drug, and groups B \& C have the same total dose. In particular this study compares different methods of assessing the sympathetic block (causing vasodilatation). These methods include skin temperature changes, hemodynamic changes and photoplethysmography.

Conditions

Interventions

TypeNameDescription
DRUGEpidural bupivacaine (dose/concentration/volume ranging)

Timeline

Start date
1999-03-01
Completion
1999-09-01
First posted
2005-09-20
Last updated
2009-03-06

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00197353. Inclusion in this directory is not an endorsement.